Vistra Corp.: Form 10-K for the period ended Dec 31, 2023
Filed with the SEC on Feb 29, 2024 and accepted by EDGAR at Feb 29, 2024, 02:35 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2023-01-01 to 2023-12-31 | $13.80bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Selling, general and administrative | 12 months2023-01-01 to 2023-12-31 | $1.31bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2023-01-01 to 2023-12-31 | $2.66bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2023-01-01 to 2023-12-31 | $740.0m | us-gaap:InterestExpense |
| Income tax | 12 months2023-01-01 to 2023-12-31 | $508.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2023-01-01 to 2023-12-31 | $1.49bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2023-01-01 to 2023-12-31 | $3.58 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2023-01-01 to 2023-12-31 | $3.63 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2023-01-01 to 2023-12-31 | 375,193,110 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2023-01-01 to 2023-12-31 | $5.45bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2023-01-01 to 2023-12-31 | $1.68bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2023-01-01 to 2023-12-31 | $313.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2023-01-01 to 2023-12-31 | $1.25bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-12-31 | $3.48bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-31 | $11.64bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $32.97bn | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $9.82bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $27.64bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-12-31 | $14.40bn | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2023-12-31 | $0 | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-12-31 | $5.31bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001692819-24-000012. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.